BEUDAMED
    FDA Adverse Event Injury Summary report: N

    INRATIO METER

    MDR report key: 9093016 · Received September 19, 2019

    Report

    Report Number
    2027969-2019-00426
    Event Type
    Injury
    Date Received
    September 19, 2019
    Report Date
    September 23, 2019
    Manufacturer
    ALERE SAN DIEGO
    Product Code
    GJS
    Removal / Correction Number
    Z-2354,2362-2016
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    GM
    Reporter Occupation
    003

    Narratives

    Additional Manufacturer Narrative · 0

    CORRECTION: COMMON DEVICE NAME INFORMATION FROM GIS TO GJS.

    Additional Manufacturer Narrative · 1

    THIS MDR IS A RETROSPECTIVE FILING THAT WAS IDENTIFIED DURING AN INTERNAL ASSESSMENT AS PART OF CAPA (B)(4) RELATED TO UNMONITORED COMMUNICATIONS CHANNELS (E-MAILS, VOICEMAILS). INVESTIGATION RESULTS: IT IS INDICATED THAT THE PRODUCT IS NOT RETURNING FOR EVALUATION. A LOT NUMBER OF THE TEST STRIP PRODUCT WAS NOT PROVIDED AND NEITHER MANUFACTURING RECORD REVIEW NOR TESTING ON RESERVE SAMPLE FROM THE SAME LOT COULD NOT BE PERFORMED. FURTHER INVESTIGATION IS NOT POSSIBLE AT THIS TIME. ALERE HAS WITHDRAWN THE ALERE INRATIO®/INRATIO®2 PT/INR SYSTEM FROM THE MARKET AND IS NO LONGER MANUFACTURING INRATIO® TEST STRIPS AND MONITORS. IN ADDITION, ALL ALERE INRATIO® TEST STRIPS ARE NOW EXPIRED. CUSTOMERS HAVE BEEN ADVISED TO WORK WITH THEIR HEALTHCARE PROVIDER TO TRANSITION TO AN ALTERNATE MONITORING METHOD, SUCH AS A PLASMA-BASED LABORATORY INR METHOD OR A POINT-OF-CARE MONITORING SYSTEM FROM A DIFFERENT MANUFACTURER.

    Description of Event or Problem · 1

    IT WAS REPORTED FROM A CUSTOMER THAT THE IN RATIO GAVE A DISCREPANT RESULT AND SHE ALLEGES THAT SHE WAS HOSPITALIZED DUE TO THE DISCREPANT RESULT. NO FURTHER INFORMATION WAS PROVIDED.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    880625 INRATIO METER INRATIO PRO TIME TEST GJS ALERE SAN DIEGO 100251

    Patients

    Seq Age Sex Outcome Treatment
    1 Hospitalization